Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach

<div>Comparison of the top five differentially expressed proteins between BBTDs and CCA. Normalized log<sub>2</sub>-transformed data were used to create box plots, in which the horizontal lines of each box correspond to the first, second, and third quartiles (25%, 50%, and 75%, resp.) and the whiskers correspond to the maximum and minimum values.</div>

Disease Markers

fig5

Figure 5

Figure 5: Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach 